NO20065903L - Ny assosiasjon av en sinusknute If strominhibitor og en kalsiuminhibitor, og farmasoytiske sammensetninger inneholdende den - Google Patents

Ny assosiasjon av en sinusknute If strominhibitor og en kalsiuminhibitor, og farmasoytiske sammensetninger inneholdende den

Info

Publication number
NO20065903L
NO20065903L NO20065903A NO20065903A NO20065903L NO 20065903 L NO20065903 L NO 20065903L NO 20065903 A NO20065903 A NO 20065903A NO 20065903 A NO20065903 A NO 20065903A NO 20065903 L NO20065903 L NO 20065903L
Authority
NO
Norway
Prior art keywords
inhibitor
pharmaceutical compositions
compositions containing
sinus node
calcium
Prior art date
Application number
NO20065903A
Other languages
English (en)
Other versions
NO337509B1 (no
Inventor
Vidal Benatar
Guy Lerebours-Pigeonniere
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37075950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20065903(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20065903L publication Critical patent/NO20065903L/no
Publication of NO337509B1 publication Critical patent/NO337509B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Assosiasjon omfattende en selektiv og spesifikk sinusknute-If-strøminhibitor, mer spesielt ivabradin, og en kalsiuminhibitor. Medikamenter.
NO20065903A 2005-12-21 2006-12-19 Ny assosiasjon av en sinusknute If strøminhibitor og en kalsiuminhibitor, og farmasøytiske sammensetninger inneholdende den NO337509B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513008A FR2894826B1 (fr) 2005-12-21 2005-12-21 Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
NO20065903L true NO20065903L (no) 2007-06-22
NO337509B1 NO337509B1 (no) 2016-05-02

Family

ID=37075950

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065903A NO337509B1 (no) 2005-12-21 2006-12-19 Ny assosiasjon av en sinusknute If strøminhibitor og en kalsiuminhibitor, og farmasøytiske sammensetninger inneholdende den

Country Status (41)

Country Link
US (3) US20070142356A1 (no)
EP (1) EP1800683B1 (no)
JP (2) JP4783275B2 (no)
KR (1) KR100907584B1 (no)
CN (1) CN101015556B (no)
AP (1) AP2208A (no)
AR (1) AR058575A1 (no)
AT (1) ATE488239T1 (no)
AU (1) AU2006252211B2 (no)
BR (1) BRPI0605516A (no)
CA (1) CA2571649C (no)
CO (1) CO5790167A1 (no)
CR (1) CR8813A (no)
CY (1) CY1111007T1 (no)
DE (1) DE602006018247D1 (no)
DK (1) DK1800683T3 (no)
EA (1) EA013536B1 (no)
ES (1) ES2356660T3 (no)
FR (1) FR2894826B1 (no)
GE (1) GEP20094603B (no)
GT (1) GT200600523A (no)
HK (1) HK1106442A1 (no)
HR (1) HRP20110028T1 (no)
IL (1) IL180209A (no)
JO (1) JO2675B1 (no)
MA (1) MA28724B1 (no)
MX (1) MXPA06014884A (no)
MY (1) MY143563A (no)
NO (1) NO337509B1 (no)
NZ (1) NZ552222A (no)
PE (1) PE20071133A1 (no)
PL (1) PL1800683T3 (no)
PT (1) PT1800683E (no)
RS (1) RS51534B (no)
SA (1) SA06270482B1 (no)
SG (1) SG133546A1 (no)
SI (1) SI1800683T1 (no)
TW (1) TWI373344B (no)
UA (1) UA91507C2 (no)
WO (1) WO2007077329A2 (no)
ZA (1) ZA200610822B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
FR2920773B1 (fr) 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
CN101564394B (zh) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 含有伊伐布雷定和曲美他嗪的药物组合物
WO2009158005A1 (en) * 2008-06-27 2009-12-30 Concert Pharmaceuticals, Inc. Benzazepinone compounds
FR2938194B1 (fr) * 2008-11-07 2012-08-31 Servier Lab Utilisation de l'ivabradine comme agent de diagnostic dans la methode d'angiographie coronaire par tomodensitometrie multicoupe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
US20030092745A1 (en) * 2000-02-25 2003-05-15 Pfizer Inc. Combination therapy
WO2003024457A1 (fr) * 2001-09-11 2003-03-27 Asahi Kasei Kabushiki Kaisha Composition medicinale pour la prevention ou le traitement des troubles vasculaires cerebraux et de la cardiopathie
US6828339B2 (en) * 2001-11-21 2004-12-07 Synthon Bv Amlodipine salt forms and processes for preparing them
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
EP1800683B1 (fr) 2010-11-17
SG133546A1 (en) 2007-07-30
US20070142356A1 (en) 2007-06-21
ZA200610822B (en) 2008-06-25
EA013536B1 (ru) 2010-06-30
CR8813A (es) 2007-06-06
AP2208A (en) 2011-02-23
GT200600523A (es) 2007-07-25
RS51534B (en) 2011-06-30
CA2571649A1 (fr) 2007-06-21
HK1106442A1 (en) 2008-03-14
CY1111007T1 (el) 2015-06-11
JP4783275B2 (ja) 2011-09-28
SA06270482B1 (ar) 2011-06-22
IL180209A0 (en) 2008-01-20
HRP20110028T1 (hr) 2011-02-28
US20090215745A1 (en) 2009-08-27
US20110230466A1 (en) 2011-09-22
CN101015556A (zh) 2007-08-15
EA200602156A1 (ru) 2007-08-31
AU2006252211B2 (en) 2012-05-17
MY143563A (en) 2011-05-31
NO337509B1 (no) 2016-05-02
ATE488239T1 (de) 2010-12-15
WO2007077329A2 (fr) 2007-07-12
ES2356660T3 (es) 2011-04-12
SI1800683T1 (sl) 2011-01-31
AR058575A1 (es) 2008-02-13
PE20071133A1 (es) 2007-12-22
PL1800683T3 (pl) 2011-04-29
JO2675B1 (en) 2012-06-17
MA28724B1 (fr) 2007-07-02
AP2006003858A0 (en) 2006-12-31
CN101015556B (zh) 2011-08-10
UA91507C2 (ru) 2010-08-10
AU2006252211A1 (en) 2007-07-05
PT1800683E (pt) 2010-12-17
CA2571649C (fr) 2012-05-22
WO2007077329A3 (fr) 2007-09-07
DE602006018247D1 (de) 2010-12-30
NZ552222A (en) 2008-05-30
TWI373344B (en) 2012-10-01
KR100907584B1 (ko) 2009-07-14
GEP20094603B (en) 2009-02-10
CO5790167A1 (es) 2007-08-31
KR20070066922A (ko) 2007-06-27
MXPA06014884A (es) 2009-02-11
JP2011068661A (ja) 2011-04-07
FR2894826A1 (fr) 2007-06-22
TW200744637A (en) 2007-12-16
IL180209A (en) 2015-05-31
DK1800683T3 (da) 2011-03-07
JP2007169284A (ja) 2007-07-05
FR2894826B1 (fr) 2010-10-22
BRPI0605516A (pt) 2007-10-16
EP1800683A1 (fr) 2007-06-27

Similar Documents

Publication Publication Date Title
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
NO20091976L (no) Nye forbindelser
IS7543A (is) Bensóþíadíasepínafleiður, aðferðir til framleiðslu þeirra og lyfjablöndur sem innihalda þær
EA200701790A1 (ru) Твёрдый фармацевтический дозированный состав
ATE448777T1 (de) Mittel für die transdermale verabreichung von nikotin
IS7883A (is) Bakteríueyðandi indólón oxasólidínón, milliefni til framleiðslu þeirra og lyfjasametningar sem innihalda þau
NO20052058D0 (no) Behandling av influensa.
NO20065903L (no) Ny assosiasjon av en sinusknute If strominhibitor og en kalsiuminhibitor, og farmasoytiske sammensetninger inneholdende den
NO20065905L (no) Ny assosiasjon av en sinusknute If strominhibitor og en angiotensinkonvertaseinhibitor, og farmasoytiske sammensetninger inneholdende den
FI20077133A (fi) Essitalopraamin kiteinen emäs ja essitalopraamiemästä sisältäviä, suussa hajoavia tabletteja
NO20063293L (no) Farmasoytiske forbindelser
IS8249A (is) Tafla sem felur í sér flúvastatín og karmellósakalsíum
EA201101119A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
NO20073071L (no) Benzotiazolformuleringer og anvendelse av disse
NO20061944L (no) Ny assosiasjon av et antiaterotrombotisk middel og et antiplateaggregerede middel
UY30022A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor de la enzima de conversion y las composiciones farmaceuticas que la contienen
CU23733A3 (es) Composición que comprende un inhibidor selectivo de la corriente sinusal if y de un inhibidor cálcico
TW200505868A (en) New synerglstic combinations

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees